Name | 5-ethyl-5-(4-hydroxyphenyl)-3-methylimidazolidine-2,4-dione |
Synonyms | 4'-Hydroxymephenitoyn 5-Ethyl-5-(4-hydroxyphenyl)-3-Methyl- 5-Ethyl-3-methyl-5-(4-hydroxyphenyl)hydantoin 4-Hydroxy-5-ethyl-3-methyl-5-phenylimidazolidin-2-one 5-ethyl-5-(4-hydroxyphenyl)-3-methylimidazolidine-2,4-dione 5-Ethyl-3-methyl-5-(4-hydroxyphenyl)imidazolidine-2,4-dione 5-(p-Hydroxyphenyl)-3-methyl-5-ethyl-imidazolidine-2,4-dione (±)-5-Ethyl-5-(4-hydroxyphenyl)-3-methylhydantoin, (±)-5-Ethyl-5-(4-hydroxyphenyl)-3-methylimididazolidine-2,4-dione |
CAS | 61837-65-8 |
InChI | InChI=1/C12H14N2O3/c1-3-12(8-4-6-9(15)7-5-8)10(16)14(2)11(17)13-12/h4-7,15H,3H2,1-2H3,(H,13,17) |
Molecular Formula | C12H14N2O3 |
Molar Mass | 234.25 |
Density | 1.249±0.06 g/cm3(Predicted) |
Melting Point | 153-154°C |
Solubility | DMSO: >5mg/mL |
Appearance | Solid |
Color | white |
pKa | 8.31±0.70(Predicted) |
Storage Condition | 2-8°C |
Refractive Index | 1.567 |
In vitro study | 4-Hydroxymephenytoin is a metabolism of mephenytoin, which is an antiepileptic drug, and used as a CYP2C19 substrate. 4-Hydroxymephenytoin (4'-Hydroxymephenytoin) is used for developing UltraPerformance LC (UPLC) tandem mass spectrometry assays for evaluating CYP probe drugs and their relevant metabolites in human urine or plasma samples. |
WGK Germany | 3 |
biological activity | 4-hydroxymephentoin is a metabolite of the antiepileptic drug mephentoin; Mephentoin is a ligand of CYP2C19. |